查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
组学研究服务市场规模份额趋势分析报告:按服务(基因组学,蛋白质组学),按业务(医院),按服务频率(单次),按产品,按最终用途,按地区,分部预测,2023-2030年
市场调查报告书
商品编码
1178600

组学研究服务市场规模份额趋势分析报告:按服务(基因组学,蛋白质组学),按业务(医院),按服务频率(单次),按产品,按最终用途,按地区,分部预测,2023-2030年

Omics Lab Services Market Size, Share & Trends Analysis Report By Services (Genomics, Proteomics), Business (Hospitals), Frequency Of Service (One-off), By Product, By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

组学研究服务的市场增长和趋势

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球组学研究服务市场规模预计将达到 1940.4 亿美元，预测期内的复合年增长率为 13.72%。市场的发展是由于基因组数据越来越多地整合到临床工作流程中，以及越来越多地采用直接面向消费者的组学。此外，对早期疾病诊断测试和技术进步的需求增加以及政府资金的增加进一步推动了整个市场的增长。

人们越来越意识到组学在人类疾病管理和其他非传统应用中的潜力，这推动了组学数据的采用。因此，寻求利用可用遗传信息引入产品和技术的公司之间的竞争日益激烈，使他们能够利用市场上充足的增长途径。先进的实验室分析还将支持精准医疗和个性化医疗的发展，并产生超越一般患者护理的影响。肿瘤学领域已经取得了长足的进步，组学和单细胞显微技术的发展极大地促进了未来以患者为中心的方法的发展。

此外，肿瘤学领域从组学研究中获益最多，NGS 临床检测的一项新兴应用是血浆中循环肿瘤 DNA (ctDNA) 的定量。可以使用多种 NGS 技术，例如通过深度测序进行癌症个性化分析。高通量 RNA 测序的发展凸显了转录组学在生物学和临床研究中的重要性。通过 NGS 技术和微阵列进行的 RNA 测序是执行转录组学的两种方法。蛋白质组学和代谢组学是两个以 NMR 和 MS 技术的改进为特征的领域。

此外，市场上的主要参与者正专注于将组学技术纳入早期诊断。例如，2021年5月，Burning Rock Biotech Limited启动了中国首个泛癌多组学早期检测研究PRESCIENT。2022年3月，PrognomiQ投资4600万美元推进用于早期癌症检测的多组学开发。2022 年 9 月，Bertis 开始了用于卵巢癌诊断的新型生物标誌物的蛋白质组学研究。此外，2022 年 7 月，Mission Bio 宣布了 Tapestri 平台，用于血液恶性肿瘤中基于单细胞多组学的 MRD 检测。这些在组学领域开发早期诊断工具的举措和研究进一步推动了整个组学研究服务市场的增长。

组学研究服务市场报告亮点

表观遗传部分预计在预测期内增长最快，这可归因于表观遗传分析提供的未来潜力

诊断实验室部分将在 2021 年占据最大的市场份额，原因是测试的增加以及执行诊断测试的更广泛资源的可用性。

硬件设备行业预计将在 2021 年主导组学研究服务市场，并在预测期内呈现最快的增长速度。这是由于通过硬件仪器的发展，基因组学和转录组学技术的快速进步。

由于基因检测的高准确性、敏感性和特异性，北美越来越多地采用基因检测，因此北美占据最大的市场份额

目录

第一章 调查方法和范围

  • 市场细分
  • 调查方法
  • 信息采购
    • 购买的数据库
    • 次要信息
    • 初步调查
    • 初步调查详情
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 型号详情
    • 商品流向分析
      • 方法一：商品流动方法
      • 方法 2：使用自下而上的方法逐个国家/地区进行市场估算
  • 全球市场：复合年增长率计算
  • 调查假设
  • 二级信息列表
  • 主要信息列表
  • 目的
  • 缩略语表

第二章执行摘要

  • 市场快照
  • 段快照
  • 竞争格局的快照

3. 组学研究服务市场变量、趋势和范围

  • 组学研究服务市场线展望
    • 母公司市场展望
      • 诊断市场
      • 生物技术市场
  • 绘製渗透率和增长前景
  • 市场驱动力分析
    • 将基因组学数据整合到临床工作流程中的进展
      • 更有针对性和个性化的医疗保健
      • 不断发展的新生儿基因筛查项目
      • 无创癌症筛查的进展
    • 越来越多地采用 D2C 组学
    • 对早期疾病诊断测试的需求不断增长
    • 技术进步
    • 增加服务的需求/采用
    • 各类企业参与度增加
    • 增加政府资助
  • 市场约束因素分析
    • 缺乏熟练的专业人员
    • 组学技术实施缓慢
  • SWOT 分析，按因素（政治和法律、经济、技术）
  • 波特五力分析
  • 监管框架

第四章组学研究服务市场-细分分析，按服务分类，2018-2030 年（百万美元）

  • 定义和范围
  • 组学研究服务市场：服务波动分析
    • 基因组学
    • 蛋白质组学
    • 转录组学
      • 转录组体内分析 (Tiva)
      • 免疫组化
      • 基于显微镜的 Rns 成像技术
    • 代谢组学
    • 表观遗传学
      • 2018-2030 年表观遗传学市场估计和预测（百万美元）

第 5 章组学研究服务市场-细分分析，按业务划分，2018-2030 年（百万美元）

  • 组学研究服务市场：业务波动分析
    • 医院
    • 调查
    • 诊断实验室

6. 组学研究服务市场——细分分析，按服务频率，2018-2030 年（百万美元）

  • 定义和范围
  • 组学研究服务市场：服务变化频率分析
    • 一次性的
    • 重复
    • 继续

第 7 章组学研究服务市场-细分分析，按产品，2018-2030 年（百万美元）

  • 定义和范围
  • 组学研究服务市场：产品变异分析
    • 硬件设备
      • 乐器
      • 耗材/试剂
    • 测试/实验室（服务）
    • 分析与解释

8. 组学研究服务市场——细分分析，按最终用途，2018-2030 年（百万美元）

  • 定义和范围
  • 组学研究服务市场：最终用途变化分析
    • 癌症
    • 製药公司
      • 处方
      • 非处方药（非处方药）
    • 再生产
    • 其他遗传病
    • 取证
      • 2018-2030 年法医市场估计和预测（百万美元）
    • 人口统计学
    • 皮肤护理
    • 营养
    • 维生素和补充剂
    • 家谱
      • 2018-2030 年家谱市场估计和预测（百万美元）
    • 其他类
      • 其他类别市场估计和预测，2018-2030（百万美元）

第九章区域业务分析

  • 定义和范围
  • 2021 年和 2030 年区域市场份额分析
  • 区域市场仪表板
  • 区域市场快照
  • SWOT 分析，按因素（政治和法律、经济和技术）
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 马雷
  • 2021-2030 年市场规模、预测和趋势分析
  • 北美
    • 美国
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 加拿大
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
  • 欧洲
    • 英国
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 德国
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 西班牙
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 法国
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 意大利
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 俄罗斯
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 丹麦
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 瑞典
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 挪威
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
  • 亚太地区
    • 日本
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 中国
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 印度
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 韩国
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 泰国
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 澳大利亚
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
  • 拉丁美洲
    • 巴西
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 墨西哥
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 阿根廷
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
  • 马雷
    • 南非
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 沙特阿拉伯
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 阿拉伯联合酋长国
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景
    • 科威特
      • 主要国家动态
      • 监管框架
      • 竞争情景
      • 最近的发展
      • 投资场景

第 10 章 竞争分析

  • 公司/竞争对手分类（主要创新者、市场领导者、初创企业）
  • 战略框架
  • 市场参与的分类
  • 主要市场进入者的最新发展和影响分析
  • 公司定位分析
  • 代理商名单
    • 主要客户
    • 上市公司
    • 民营企业
  • 案例分析
    • 案例研究：基于血液的 NGS 在非小细胞肺癌 (Nsclc) 治疗决策中的应用
      • NGS对急性髓性白血病治疗方案的影响
    • 案例研究：预测癌症治疗反应
      • 挑战：了解对免疫检查点抑製剂治疗的反应
      • 见解：代谢组学识别免疫检查点抑製剂治疗应答者的不同代谢物
      • 解决方案：与无反应者相比，免疫检查点抑製剂治疗反应者俱有不同的代谢组学特征
      • 结果：代谢组学确定了治疗反应的预测性生物标誌物
    • 案例研究：临床试验设计
      • 任务
      • 代谢酮洞察力
      • 解决方案
      • 结果
    • 案例研究：幽门螺桿菌如何形成
      • 任务
      • 方法
      • 结果
    • 案例研究：基因组诊断中 Cnv 和 Snv 的联合分析
      • 分析
      • 结果：
      • 结论

第十一章公司简介

  • 公司简介
    • AGILENT TECHNOLOGIES, INC.
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • BEIJING GENOMICS INSTITUTE（BGI）
      • 公司简介
      • Complete Genomics Inc.
      • 产品基准
      • 战略举措
    • Q2 SOLUTIONS
      • 公司简介
      • 产品基准
      • 战略举措
    • SPECTRUS
      • 公司简介
      • 产品基准
    • FLOMICS BIOTECH
      • 公司简介
      • 产品基准
      • 战略举措
    • PHENOSWITCH BIOSCIENCE
      • 公司简介
      • 产品基准
      • 战略举措
    • QIAGEN
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • QUEST DIAGNOSTICS INCORPORATED
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
    • THERMO FISHER SCIENTIFIC, INC.
      • 公司简介
      • Life Technologies Co., Ltd.
      • Affymetrix
      • Applied Biosystems
      • 财务绩效
      • 产品基准
      • 战略举措
    • ILLUMINA, INC
      • 公司简介
      • 财务绩效
      • 产品基准
      • 战略举措
Product Code: GVR-4-68040-014-8

Omics Lab Services Market Growth & Trends:

The global omics lab services market size is expected to reach USD 194.04 billion by 2030, registering CAGR of 13.72% during the forecast period, according to a new report by Grand View Research, Inc. The development of the market is attributed to growing integration of the genomics data into clinical workflow and rising adoption of direct-to-consumer omics. Moreover, rising demand for early disease diagnostic test, technological advancements aided with increasing government funding is further propelling growth of the overall market.

Growing recognition of omics' potential in human disease management and other nonconventional applications has fueled the implementation of omics data. This, in turn, has increased competition among firms to introduce products and technologies by leveraging available genetic information, capitalizing on the ample growth avenues in the market. Advanced laboratory analytics also support the development of precision and personalized medicine, which has an influence beyond general patient care. Thorough progress has already been made in the field of oncology, and developments in omics and single-cell micro technology have greatly benefited progress toward upcoming patient-centered approach.

Moreover, the field of oncology has benefited most from omics research, and one newly developed use of NGS clinical tests is for the quantification of circulating tumor DNA (ctDNA) from plasma. Numerous NGS technologies, such as Cancer Personalized Profiling by deep Sequencing, may be used. High-throughput RNA sequencing developments have brought light the importance of transcriptomics in biological and clinical research. RNA sequencing using NGS technologies or microarrays are two ways to perform transcriptomics. Proteomics and metabolomics are two domains that have been significantly characterized by improvements in NMR and MS technologies.

Furthermore, key players operating in the market are focusing on incorporating omics technology in early diagnosis. For instance, in May 2021, Burning Rock Biotech Limited launched PRESCIENT, first pan cancer, multi omics early detection study in China. In March 2022, PrognomiQ invested USD 46.0 million in advancing development of multiomics for early detection of cancer. In September 2022, Bertis launched Proteomic based research of its new biomarkers for diagnosis of ovarian cancer. Moreover, in July 2022, Mission Bio, Inc. launched Tapestri platform for single cell multiomics-based MRD detection in blood cancers. These initiatives and research in the field of omics for the development of early diagnosis tools is further propelling the overall omics labs services market growth.

Omics Lab Services Market Report Highlights:

  • Epigenetic segment is expected to show fastest growth during the forecast period which can be attributed to the future potential offered by epigenetic analysis
  • Diagnostic labs segment held the largest market share in 2021 owing to the rising testing and availability of the wide range of resources for performing diagnostic tests
  • Hardware equipment segment dominated the omics lab services market in 2021 and is anticipated to show at fastest growth rate during the forecast period owing to Rapid technological advancements in genomics and transcriptomics through the development of hardware equipments
  • North America held the largest market share which can be attributed to the increasing adoption of genetic testing due to its high accuracy, sensitivity, and specificity

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Secondary Sources
    • 1.3.3 Primary Research
    • 1.3.4 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach 1: Commodity Flow Approach
      • 1.6.1.2 Approach 2: Country Wise Market Estimation Using Bottom-Up Approach
  • 1.7 Global Market: Cagr Calculation
  • 1.8 Research Assumptions
  • 1.9 List Of Secondary Sources
  • 1.10 List Of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:
  • 1.12 List Of Abbreviations

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Omics Lab Services Market Variables, Trends, and Scope

  • 3.1 Omics Lab Services Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
      • 3.1.1.1 Diagnostics Market
      • 3.1.1.2 Biotechnology Market
  • 3.2 Penetration And Growth Prospect Mapping
  • 3.3 Market Driver Analysis
    • 3.3.1 Growing Integration Of Genomics Data Into Clinical Workflows
      • 3.3.1.1 More Targeted And Personalized Healthcare
      • 3.3.1.2 Growth Of Newborn Genetic Screening Programs
      • 3.3.1.3 Advancements In Noninvasive Cancer Screening
    • 3.3.2 Rising Adoption Of Direct-To-Consumer Omics
    • 3.3.3 Rising Demand For Early Disease Diagnostic Tests
    • 3.3.4 Technological Advancements
    • 3.3.5 Increasing Demand/ Adoption For Services
    • 3.3.6 Increasing Participation Of Different Companies
    • 3.3.7 Increasing Government Funding
  • 3.4 Market Restraint Analysis
    • 3.4.1 Lack Of Skilled Professionals
    • 3.4.2 Slow Implementation Of Omics Technology
  • 3.5 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
  • 3.6 Porter's Five Forces Analysis
  • 3.7 Regulatory Framework

Chapter 4 Omics Lab Services Market - Segment Analysis, By Service, 2018 - 2030 (USD Million)

  • 4.1 Definition And Scope
  • 4.2 Omics Lab Services Market: Service Movement Analysis
    • 4.2.1 Genomics
      • 4.2.1.1 Genomics Lab Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.2 Proteomics
      • 4.2.2.1 Proteomics Lab Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.3 Transcriptomics
      • 4.2.3.1 Transcriptome In-Vivo Analysis (Tiva)
      • 4.2.3.2 Ihc
      • 4.2.3.3 Microscopy-Based Rns Imaging Techniques
      • 4.2.3.4 Transcriptomics Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.4 Metabolomics
      • 4.2.4.1 Metabolomics Lab Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 4.2.5 Epigenetics
      • 4.2.5.1 Epigenetics Market Estmates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 Omics Lab Services Market - Segment Analysis, By Business, 2018 - 2030 (USD Million)

  • 5.1 Omics Lab Services Market: Business Movement Analysis
    • 5.1.1 Hospitals
      • 5.1.1.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.1.2 Research Institutes
      • 5.1.2.1 Research Institutes Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.1.3 Diagnostic Labs
      • 5.1.3.1 Diagnostic Labs Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Omics Lab Services Market - Segment Analysis, By Frequency Of Service, 2018 - 2030 (USD Million)

  • 6.1 Definition And Scope
  • 6.2 Omics Lab Services Market: Frequency Of Service Movement Analysis
    • 6.2.1 One-Off
      • 6.2.1.1 One-Off Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 Repeat
      • 6.2.2.1 Repeat Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.3 Continuous
      • 6.2.3.1 Continuous Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Omics Lab Services Market - Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 7.1 Definition And Scope
  • 7.2 Omics Lab Services Market: Product Movement Analysis
    • 7.2.1 Hardware Equipment
      • 7.2.1.1 Instruments
      • 7.2.1.2 Consumables/Reagents
      • 7.2.1.3 Hardware Equipment Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.2 Testing/Lab (Services)
      • 7.2.2.1 Testing/Lab Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.2.3 Analytics/Interpretation
      • 7.2.3.1 Analytics/Interpretation Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Omics Lab Services Market - Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 8.1 Definition And Scope
  • 8.2 Omics Lab Services Market: End-Use Movement Analysis
    • 8.2.1 Cancer
      • 8.2.1.1 Cancer Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2 Pharmaco
      • 8.2.2.1 Pharmaco Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.2.2.2 Prescription
      • 8.2.2.2.1 Prescription Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 8.2.2.3 Non-Prescription (Otc)
      • 8.2.2.3.1 Non-Prescription Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.3 Reproductive
      • 8.2.3.1 Reproductive Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.4 Other Genetic Disease
      • 8.2.4.1 Other Genetic Disease Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.5 Forensics
      • 8.2.5.1 Forensics Market Estmates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.6 Population Studies
      • 8.2.6.1 Population Studies Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.7 Skincare
      • 8.2.7.1 Skincare Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.8 Nutrition
      • 8.2.8.1 Nutrition Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.9 Vitamins And Supplements
      • 8.2.9.1 Vitamins And Supplements Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.10 Genealogy
      • 8.2.10.1 Genealogy Market Estmates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.11 Other Categories
      • 8.2.11.1 Other Categories Market Estmates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 Regional Business Analysis

  • 9.1 Definition & Scope
  • 9.2 Regional Market Share Analysis, 2021&2030
  • 9.3 Regional Market Dashboard
  • 9.4 Regional Market Snapshot
  • 9.5 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
    • 9.5.1 North America
    • 9.5.2 Europe
    • 9.5.3 Asia Pacific
    • 9.5.4 Latin America
    • 9.5.5 Mea
  • 9.6 Market Size, & Forecasts, Trend Analysis, 2021 To 2030
  • 9.7 North America
    • 9.7.1 North America Market Estimates And Forecast, 2018 - 2030 (USD Billion)
    • 9.7.2 U.S.
      • 9.7.2.1 U.S. Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.7.2.2 Key Country Dynamics
      • 9.7.2.3 Regulatory Framework
      • 9.7.2.4 Competitive Scenario
      • 9.7.2.5 Recent Developments
      • 9.7.2.6 Investments Scenario
    • 9.7.3 Canada
      • 9.7.3.1 Canada Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.7.3.2 Key Country Dynamics
      • 9.7.3.3 Regulatory Framework
      • 9.7.3.4 Competitive Scenario
      • 9.7.3.5 Recent Developments
      • 9.7.3.6 Investments Scenario
  • 9.8 Europe
    • 9.8.1 Urope Omics Lab Services Market, 2018 - 2030 (USD Billion)
    • 9.8.2 Uk
      • 9.8.2.1 Uk Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.2.2 Key Country Dynamics
      • 9.8.2.3 Regulatory Framework
      • 9.8.2.4 Competitive Scenario
      • 9.8.2.5 Recent Developments
      • 9.8.2.6 Investments Scenario
    • 9.8.3 Germany
      • 9.8.3.1 Germany Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.3.2 Key Country Dynamics
      • 9.8.3.3 Regulatory Framework
      • 9.8.3.4 Competitive Scenario
      • 9.8.3.5 Recent Developments
      • 9.8.3.6 Investments Scenario
    • 9.8.4 Spain
      • 9.8.4.1 Spain Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.4.2 Key Country Dynamics
      • 9.8.4.3 Regulatory Framework
      • 9.8.4.4 Competitive Scenario
      • 9.8.4.5 Recent Developments
      • 9.8.4.6 Investments Scenario
    • 9.8.5 France
      • 9.8.5.1 France Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.5.2 Key Country Dynamics
      • 9.8.5.3 Regulatory Framework
      • 9.8.5.4 Competitive Scenario
      • 9.8.5.5 Recent Developments
      • 9.8.5.6 Investments Scenario
    • 9.8.6 Italy
      • 9.8.6.1 Italy Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.6.2 Key Country Dynamics
      • 9.8.6.3 Regulatory Framework
      • 9.8.6.4 Competitive Scenario
      • 9.8.6.5 Recent Developments
      • 9.8.6.6 Investments Scenario
    • 9.8.7 Russia
      • 9.8.7.1 Russia Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.7.2 Regulatory Framework
      • 9.8.7.3 Competitive Scenario
      • 9.8.7.4 Recent Developments
      • 9.8.7.5 Investments Scenario
    • 9.8.8 Denmark
      • 9.8.8.1 Denmarkomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.8.2 Key Country Dynamics
      • 9.8.8.3 Regulatory Framework
      • 9.8.8.4 Competitive Scenario
      • 9.8.8.5 Recent Developments
      • 9.8.8.6 Investments Scenario
    • 9.8.9 Sweden
      • 9.8.9.1 Sweden Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.9.2 Key Country Dynamics
      • 9.8.9.3 Regulatory Framework
      • 9.8.9.4 Competitive Scenario
      • 9.8.9.5 Recent Developments
      • 9.8.9.6 Investments Scenario
    • 9.8.10 Norway
      • 9.8.10.1 Norway Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.8.10.2 Key Country Dynamics
      • 9.8.10.3 Regulatory Framework
      • 9.8.10.4 Competitive Scenario
      • 9.8.10.5 Recent Developments
      • 9.8.10.6 Investments Scenario
  • 9.9 Asia Pacific
    • 9.9.1 Asia-Pacific Omics Lab Services Market, 2018 - 2030 (USD Billion)
    • 9.9.2 Japan
      • 9.9.2.1 Japan Omics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.9.2.2 Key Country Dynamics
      • 9.9.2.3 Regulatory Framework
      • 9.9.2.4 Competitive Scenario
      • 9.9.2.5 Recent Developments
      • 9.9.2.6 Investments Scenario
    • 9.9.3 China
      • 9.9.3.1 Chinaomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.9.3.2 Key Country Dynamics
      • 9.9.3.3 Regulatory Framework
      • 9.9.3.4 Competitive Scenario
      • 9.9.3.5 Recent Developments
      • 9.9.3.6 Investments Scenario
    • 9.9.4 India
      • 9.9.4.1 Indiaomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.9.4.2 Key Country Dynamics
      • 9.9.4.3 Regulatory Framework
      • 9.9.4.4 Competitive Scenario
      • 9.9.4.5 Recent Developments
      • 9.9.4.6 Investments Scenario
    • 9.9.5 South Korea
      • 9.9.5.1 South Koreaomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.9.5.2 Key Country Dynamics
      • 9.9.5.3 Regulatory Framework
      • 9.9.5.4 Competitive Scenario
      • 9.9.5.5 Recent Developments
      • 9.9.5.6 Investments Scenario
    • 9.9.6 Thailand
      • 9.9.6.1 Thailandomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.9.6.2 Key Country Dynamics
      • 9.9.6.3 Regulatory Framework
      • 9.9.6.4 Competitive Scenario
      • 9.9.6.5 Recent Developments
      • 9.9.6.6 Investments Scenario
    • 9.9.7 Australia
      • 9.9.7.1 Australiaomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.9.7.2 Key Country Dynamics
      • 9.9.7.3 Regulatory Framework
      • 9.9.7.4 Competitive Scenario
      • 9.9.7.5 Recent Developments
      • 9.9.7.6 Investments Scenario
  • 9.10 Latin America
    • 9.10.1 Latin America Omics Lab Services Market, 2018 - 2030 (USD Billion)
    • 9.10.2 Brazil
      • 9.10.2.1 Brazilomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.10.2.2 Key Country Dynamics
      • 9.10.2.3 Regulatory Framework
      • 9.10.2.4 Competitive Scenario
      • 9.10.2.5 Recent Developments
      • 9.10.2.6 Investments Scenario
    • 9.10.3 Mexico
      • 9.10.3.1 Mexicoomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.10.3.2 Key Country Dynamics
      • 9.10.3.3 Regulatory Framework
      • 9.10.3.4 Competitive Scenario
      • 9.10.3.5 Recent Developments
      • 9.10.3.6 Investments Scenario
    • 9.10.4 Argentina
      • 9.10.4.1 Argentinaomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.10.4.2 Key Country Dynamics
      • 9.10.4.3 Regulatory Framework
      • 9.10.4.4 Competitive Scenario
      • 9.10.4.5 Recent Developments
      • 9.10.4.6 Investments Scenario
  • 9.11 Mea
    • 9.11.1 Mea Omics Lab Services Market, 2018 - 2030 (USD Billion)
    • 9.11.2 South Africa
      • 9.11.2.1 South Africaomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.11.2.2 Key Country Dynamics
      • 9.11.2.3 Regulatory Framework
      • 9.11.2.4 Competitive Scenario
      • 9.11.2.5 Recent Developments
      • 9.11.2.6 Investments Scenario
    • 9.11.3 Saudi Arabia
      • 9.11.3.1 Saudi Arabiaomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.11.3.2 Key Country Dynamics
      • 9.11.3.3 Regulatory Framework
      • 9.11.3.4 Competitive Scenario
      • 9.11.3.5 Recent Developments
      • 9.11.3.6 Investments Scenario
    • 9.11.4 Uae
      • 9.11.4.1 Uaeomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.11.4.2 Key Country Dynamics
      • 9.11.4.3 Regulatory Framework
      • 9.11.4.4 Competitive Scenario
      • 9.11.4.5 Recent Developments
      • 9.11.4.6 Investments Scenario
    • 9.11.5 Kuwait
      • 9.11.5.1 Kuwaitomics Lab Services Market, 2018 - 2030 (USD Billion)
      • 9.11.5.2 Key Country Dynamics
      • 9.11.5.3 Regulatory Framework
      • 9.11.5.4 Competitive Scenario
      • 9.11.5.5 Recent Developments
      • 9.11.5.6 Investments Scenario

Chapter 10 Competitive Analysis

  • 10.1 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
  • 10.2 Strategy Framework
  • 10.3 Market Participation Categorization
  • 10.4 Recent Developments & Impact Analysis, By Key Market Participants
  • 10.5 Company Position Analysis
  • 10.6 List Of Distributors
    • 10.6.1 Key Customers
    • 10.6.2 Public Companies
    • 10.6.3 Private Companies
  • 10.7 Case Studies
    • 10.7.1 Case Study: Blood-Based Ngs In Treatment Decision-Making For Non-Small Cell Lung Cancer (Nsclc)
      • 10.7.1.1 Impact Of Ngs On Treatment Selection In Acute Myeloid Leukemia
    • 10.7.2 Case Study: Cancer Treatment Response Prediction
      • 10.7.2.1 The Challenge: Understanding Immune Checkpoint Inhibitor Therapy Response
      • 10.7.2.2 Insight: Metabolomics Identifies Differential Metabolites In Responders To Immune Checkpoint Inhibitor Therapy
      • 10.7.2.3 The Solution: Immune Checkpoint Inhibitor Therapy Responders Have Different Metabolomic Profiles Compared To Non-Responders
      • 10.7.2.4 The Result: Metabolomics Identifies Predictive Biomarkers For Treatment Response
    • 10.7.3 Case Study: Clinical Trial Design
      • 10.7.3.1 The Challenge
      • 10.7.3.2 Metabolon Insight
      • 10.7.3.3 The Solution
      • 10.7.3.4 The Outcome
    • 10.7.4 Case Study: How H. Pylori Get Its Shape
      • 10.7.4.1 The Challenge
      • 10.7.4.2 The Approach
      • 10.7.4.3 The Outcome
    • 10.7.5 Case Study: Combined Analysis Of Cnvs And Snvs In Genomic Diagnostics
      • 10.7.5.1 Analysis
      • 10.7.5.2 Result:
      • 10.7.5.3 Conclusion

Chapter 11 Company Profiles

  • 11.1 Company Profiles
    • 11.1.1 AGILENT TECHNOLOGIES, INC.
      • 11.1.1.1 Company Overview
      • 11.1.1.2 Financial Performance
      • 11.1.1.3 Product Benchmarking
      • 11.1.1.4 Strategic Initiatives
    • 11.1.2 BEIJING GENOMICS INSTITUTE (BGI)
      • 11.1.2.1 Company Overview
      • 11.1.2.1.1Complete Genomics Incorporated
      • 11.1.2.2 Product Benchmarking
      • 11.1.2.3 Strategic Initiatives
    • 11.1.3 Q2 SOLUTIONS
      • 11.1.3.1 Company Overview
      • 11.1.3.2 Product Benchmarking
      • 11.1.3.3 Strategic Initiatives
    • 11.1.4 SPECTRUS
      • 11.1.4.1 Company Overview
      • 11.1.4.2 Product Benchmarking
    • 11.1.5 FLOMICS BIOTECH
      • 11.1.5.1 Company Overview
      • 11.1.5.2 Product Benchmarking
      • 11.1.5.3 Strategic Initiatives
    • 11.1.6 PHENOSWITCH BIOSCIENCE
      • 11.1.6.1 Company Overview
      • 11.1.6.2 Product Benchmarking
      • 11.1.6.3 Strategic Initiatives
    • 11.1.7 QIAGEN
      • 11.1.7.1 Company Overview
      • 11.1.7.1 Financial Performance
      • 11.1.7.2 Product Benchmarking
      • 11.1.7.3 Strategic Initiatives
    • 11.1.8 QUEST DIAGNOSTICS INCORPORATED
      • 11.1.8.1 Company Overview
      • 11.1.8.2 Financial Performance
      • 11.1.8.3 Product Benchmarking
      • 11.1.8.4 Strategic Initiatives
    • 11.1.9 THERMO FISHER SCIENTIFIC, INC.
      • 11.1.9.1 Company Overview
      • 11.1.9.1.1 Life Technologies Corp.
      • 11.1.9.1.2 Affymetrix
      • 11.1.9.1.3 Applied Biosystems
      • 11.1.9.2 Financial Performance
      • 11.1.9.3 Product Benchmarking
      • 11.1.9.4 Strategic Initiatives
    • 11.1.10 ILLUMINA, INC
      • 11.1.10.1 Company Overview
      • 11.1.10.2 Financial Performance
      • 11.1.10.3 Product Benchmarking
      • 11.1.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Regulatory Framework
  • Table 4 Global Omics Lab Services Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 6 Global Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 7 Global Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 8 Global Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 9 Global Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 10 North America Omics Lab Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 11 North America Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 12 North America Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 13 North America Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 14 North America Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 15 North America Omics Lab Services Market, By End-use, 2018 - 2030 (USD Million)
  • Table 16 U.S. Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 17 U.S. Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 18 U.S. Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 19 U.S. Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 20 U.S. Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 21 Canada Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 22 Canada Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 23 Canada Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 24 Canada Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 25 Canada Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26 Europe Omics Lab Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 27 Europe Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 28 Europe Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 29 Europe Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 30 Europe Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 31 Europe Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32 UK Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 33 UK Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 34 UK Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 35 UK Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 36 UK Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 37 Germany Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 38 Germany Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 39 Germany Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 40 Germany Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 41 Germany Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 42 France Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 43 France Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 44 France Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 45 France Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 46 France Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47 Spain Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 48 Spain Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 49 Spain Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 50 Spain Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 51 Spain Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 52 Italy Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 53 Italy Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 54 Italy Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 55 Italy Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 56 Italy Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57 Denmark Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 58 Denmark Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 59 Denmark Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 60 Denmark Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 61 Denmark Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 62 Sweden Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 63 Sweden Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 64 Sweden Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 65 Sweden Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 66 Sweden Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 67 Norway Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 68 Norway Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 69 Norway Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 70 Norway Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 71 Norway Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific Omics Lab Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78 Japan Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 79 Japan Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 80 Japan Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 81 Japan Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 82 Japan Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 83 China Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 84 China Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 85 China Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 86 China Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 87 China Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 88 Australia Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 89 Australia Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 90 Australia Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 91 Australia Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 92 Australia Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 93 Thailand Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 94 Thailand Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 95 Thailand Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 96 Thailand Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 97 Thailand Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 98 India Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 99 India Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 100 India Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 101 India Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 102 India Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 103 South Korea Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 104 South Korea Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 105 South Korea Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 106 South Korea Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 107 South Korea Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 108 Latin America Omics Lab Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 109 Latin America Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 110 Latin America Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 111 Latin America Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 112 Latin America Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 113 Latin America Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 114 Mexico Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 115 Mexico Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 116 Mexico Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 117 Mexico Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 118 Mexico Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 119 Brazil Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 120 Brazil Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 121 Brazil Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 122 Brazil Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 123 Brazil Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 124 Argentina Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 125 Argentina Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 126 Argentina Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 127 Argentina Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 128 Argentina Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 129 MEA Omics Lab Services Market, By Country, 2018 - 2030 (USD Million)
  • Table 130 MEA Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 131 MEA Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 132 MEA Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 133 MEA Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 134 MEA Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 135 South Africa Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 136 South Africa Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 137 South Africa Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 138 South Africa Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 139 South Africa Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 140 South Africa Omics Lab Services Market, By End-use, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 144 Saudi Arabia Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 145 Saudi Arabia Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 146 Saudi Arabia Omics Lab Services Market, By End-use, 2018 - 2030 (USD Million)
  • Table 147 UAE Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 148 UAE Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 149 UAE Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 150 UAE Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 151 UAE Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)
  • Table 152 Kuwait Omics Lab Services Market, By Services, 2018 - 2030 (USD Million)
  • Table 153 Kuwait Omics Lab Services Market, By Business, 2018 - 2030 (USD Million)
  • Table 154 Kuwait Omics Lab Services Market, By Frequency of Service, 2018 - 2030 (USD Million)
  • Table 155 Kuwait Omics Lab Services Market, By Product, 2018 - 2030 (USD Million)
  • Table 156 Kuwait Omics Lab Services Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Omics lab services market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot (Service, Business)
  • Fig. 11 Segment snapshot (Frequency of Service, Product)
  • Fig. 12 Segment snapshot (End-Use)
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Penetration & growth prospect mapping
  • Fig. 15 Omics lab services market driver impact
  • Fig. 16 Categories of tests offered by DTC companies
  • Fig. 17 Benefits of earlier detection of cancer
  • Fig. 18 Use of cancer biomarkers in cancer management
  • Fig. 19 Adoption of Omics services
  • Fig. 20 Omics lab services market restraint impact
  • Fig. 21 SWOT analysis, by factor (Political & legal, economic, and technological)
  • Fig. 22 Porter's five forces analysis
  • Fig. 23 Omics lab services market: Service outlook and key takeaways
  • Fig. 24 Omics lab services market: Service movement analysis
  • Fig. 25 Genomics Players
  • Fig. 26 Genomics lab services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Proteomics Players
  • Fig. 28 Proteomics Landscape
  • Fig. 29 Proteomics lab services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Transcriptomics lab services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Metabolomics lab services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Epigenetics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Omics lab services market : Business outlook and key takeaways
  • Fig. 34 Omics lab services market: Business movement analysis
  • Fig. 35 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Research institutes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Diagnostic labs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Omics lab services market : Frequency of service outlook and key takeaways
  • Fig. 39 Omics lab services market: Frequency of service movement analysis
  • Fig. 40 One-off market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Repeat market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Continuous market estimates and forecast,, 2018 - 2030 (USD Million)
  • Fig. 43 Omics lab services market : Product outlook and key takeaways
  • Fig. 44 Omics lab services market: Product movement analysis
  • Fig. 45 Hardware equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Testing/Lab market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Analytics/Interpretation market estimates and forecast,, 2018 - 2030 (USD Million)
  • Fig. 48 Omics lab services market: End-use outlook and key takeaways
  • Fig. 49 Omics lab services market: End-use movement analysis
  • Fig. 50 Multi-omics approach in cancer screening
  • Fig. 51 Cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Pharmaco market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Prescription market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Non-Prescription market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Reproductive market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Other genetic disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Relationship between omics and phenotypes
  • Fig. 58 Forensics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Population studies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Skincare market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Nutrition market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Vitamins and supplements market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Genealogy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 64 Other categories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Regional marketplace: Key takeaway
  • Fig. 66 Omics lab services market: Regional movement analysis
  • Fig. 67 Global omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 68 North America omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 69 Europe omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 70 Asia Pacific omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 71 Latin America omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 72 Middle East & Africa omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 73 Australia omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 74 Singapore omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 75 GCC omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 76 UAE omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 77 Rest of GCC omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 78 UK omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 79 Thailand omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 80 ASEAN countries omics lab services market, 2018 - 2030 (USD Million)
  • Fig. 81 Ansoff Matrix
  • Fig. 82 Strategy mapping
  • Fig. 83 Companies operating in the market
  • Fig. 84 Potentially actionable genes considered during the study
  • Fig. 85 Study results
  • Fig. 86 Workflow overview of tiered analysis approach developed at UMC Utrecht and implemented with Alissa Interpret
  • Fig. 87 Results of the tiered approach